General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
Do not rely on the original June 2026 announcement
TMHP originally announced a June 2026 move to the Vendor Drug Program formulary. A later notice dated May 1, 2026 postponed that addition until further notice. The official delay announcement is the relevant update identified in this review. Do not treat the earlier planned date as proof that pharmacy billing is available today.
When calling, ask a precise question: “For this product and my current plan, which benefit processes the claim now?” If someone refers to a transition, ask for the current implementation notice and effective date. Save the answer with the date of the conversation so the next office does not repeat an outdated instruction.
Understand the published DME framework
The Texas Medicaid DME and Supplies Handbook describes a personal CGM benefit with prior authorization. It includes a dedicated receiver requirement and clinical pathways involving insulin treatment or specified hypoglycemia circumstances. The treating practitioner’s documentation and the prescribed system determine whether the request meets the applicable criteria.
A product’s ability to display readings on a phone does not answer whether the payer requires a receiver. Ask the dispensing provider to check the entire prescribed system, rather than requesting only the component you can see in an online catalog. Your clinician should decide the appropriate monitoring configuration.
Identify the decision maker on your coverage
Before discussing a device, have your current membership card available for a private call with the program or plan. Ask whether the request is being handled under fee for service or through your managed care organization. Then confirm the appropriate authorization contact and the provider directory for that pathway.
Keep a short call log: plan name, department, date, representative reference and the next action. If the plan names an approved supplier, ask that supplier whether it can handle the exact model and delivery address. A national shipping capability does not establish Medicaid enrollment, network participation or permission to bill your particular plan.
Give the prescribing office a clear request
Instead of asking the office only to “send a CGM,” explain whether this is a first prescription, a routine supply refill, a lost receiver or a change to another system. Ask the office to verify that the prescription and supporting records name the same device. Confirm who will respond if the reviewer asks for missing documentation.
- Ask whether the request includes every required component.
- Confirm where the office should send the authorization material.
- Ask how you will be notified when the request is submitted.
- Identify the person to call if no decision arrives within the timeframe the plan provides.
Do not alter your monitoring or insulin plan while an administrative request is pending. Discuss any supply gap with your treating professional.
Separate an authorization problem from a supply problem
When a refill is delayed, ask which stage is incomplete. The answer may be a prescription renewal, a pending authorization, a timing restriction, an unresolved primary payer claim, or the dispenser’s ability to obtain the exact item. These are different problems and may involve different people.
Request the actual notice rather than relying on a verbal “not covered.” Record the requested model and quantity, the decision date, and the appeal or correction instructions. Ask whether the prescriber should submit missing information or whether a formal review is required. Do not assume that changing suppliers will correct a clinical documentation issue.
Plan refills and transfers without duplicate requests
Before switching, ask the current dispenser whether a shipment or claim is already pending. Ask the new provider to confirm its ability to bill your program and whether it needs a new authorization. Keep the last dispensing date and remaining supplies available during that discussion, but share them through the provider’s appropriate channel.
If you need a manufacturer replacement for a failed sensor, keep that request separate from the next scheduled insurance supply. For children, ask the plan and clinician about applicable pediatric review rules. For Medicare and Medicaid together, ask which payer must act first. Neither situation should be decided from a general website guide.
MedraxDME is an out of network supplier. This educational page does not establish Medicaid enrollment, a contract with your plan, or your eligibility to receive equipment from us. Confirm the dispensing provider with your program before transferring a prescription. Our online form requests contact details and optional equipment selections. Do not enter insurance numbers, medical records or glucose readings.
Questions and answers
Did Texas automatically move CGMs to pharmacy coverage in June 2026?
The official TMHP update postponed that planned addition until further notice. Ask your plan for the currently active route.
Is a phone app enough for the Texas DME request?
The published DME handbook includes a dedicated receiver requirement. Have the dispensing provider check the exact prescribed system.
Can MedraxDME guarantee Texas Medicaid approval?
No. Individual coverage, provider enrollment and the dispensing arrangement must be confirmed before supply is arranged.
Sources and updates
- TMHP notice postponing the pharmacy formulary addition
- Texas Medicaid DME and Supplies Handbook, CGM section
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.